Syphilis Treatment Drugs Market Size & Share, by Disease Type (Primary, Secondary, Tertiary Syphilis); Distribution Channel (Hospital, Retail, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3072
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Syphilis Treatment Drugs Market size is expected to register remarkable growth rate during the forecast period i.e., between 2024-2036. 

The growth of the syphilis treatment drugs market can be attributed to growing number of incidences of unprotected sex, anonymous sex and intercourse under the influence of drugs. According to the United States Centers for Disease Control and Prevention (CDC), in 2019, nearly 46% of sexually active high school students did not use a condom the last time they had sex. Half of the cases of STD are reported among people aged between 15-24 years. In addition to these, growing prevalence of syphilis in developing nations is also expected to drive market growth in the near future. Furthermore, as the prevalence of sexually transmitted diseases (STDs) is increasing, the sales of treatment drugs are also evaluated to witness a major surge in the coming years, which in turn is assessed to boost the market growth.


Syphilis-Treatment-Drugs-Market
Get more information on this report: Request Free Sample PDF

Syphilis Treatment Drugs Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Incidences of Unprotected Sex Worldwide
  • Growing Occurrence of Syphilis in Developing Nations

Challenges

  • Lack of Trained Laboratory Personnel in Under Developed Nations

Syphilis Treatment Drugs Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Syphilis Treatment Drugs Segmentation

The market is segmented by disease type into primary, secondary, tertiary syphilis, and others, out of which, the primary and secondary syphilis segments are anticipated to hold the largest share in the syphilis treatment drugs market on account of the commonness of the disease in its earlier and transmissible stages. Additionally, majority of the cases of primary and secondary syphilis occur among homosexual men. Another report by the CDC states, in 2019, of the total syphilis cases, 38,992 were of primary and secondary (P&S) syphilis. Out of these, 56% of the total incidents accounted for all male cases. Rising openness towards same-sex is also estimated to offer opportunities to the growth of this market segment in the near future. Moreover, based on distribution channel, the segment for hospital pharmacies is evaluated to occupy the largest market share during the forecast period, which can be credited to the ease to receive prescribed medicines from the hospital facility itself. 

Our in-depth analysis of the global market includes the following segments

By Disease Type

  • Primary Syphilis
  • Secondary Syphilis
  • Tertiary Syphilis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Syphilis Treatment Drugs Industry - Regional Synopsis

North America Market Statistics

On the basis of geographical analysis, the syphilis treatment drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is predicted to dominate majority revenue share by 2036, on the back of high awareness about the disease, favorable public health insurance plans and growing advancements in the healthcare sector.

Europe Market Analysis

Europe is also assessed to acquire a large share in the syphilis treatment drugs market during the forecast period owing to the rising R&D activities to develop effective treatment for STDs in the region. However, the market in the Middle East & Africa is projected to witness noteworthy growth over the forecast period, which can be ascribed to increasing occurrence of syphilis in Africa, emergence of new point-of-care (POC) testing concepts and increasing number of public health labs to provide STD testing. According to the World Health Organization (WHO), Africa accounted for the highest prevalence of syphilis in the world.

Research Nester
Syphilis-Treatment-Drugs-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Syphilis Treatment Drugs Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • F. Hoffman-La Roche Ltd
    • Abbott Laboratories
    • PerkinElmer, Inc.
    • Merck & Co., Inc.
    • Bristol-Myers Squibb Company
    • Gilead Sciences, Inc.
    • Sandoz GmbH

Author Credits:  Radhika Pawar


  • Report ID: 3072
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of unprotected sex worldwide and growing occurrence of syphilis in developing nations are major growth drivers for the market.

The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2021 – 2029.

Lack of trained laboratory personnel in under developed nations is estimated to hamper the market growth.

Middle East & Africa region will provide more business growth opportunities on the back of high prevalence of syphilis in Africa.

The major players in the market are GlaxoSmithKline plc, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, PerkinElmer, Inc., and others.
Syphilis Treatment Drugs Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample